Business Context and Reporting Period
Company: Harvard Bioscience, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: March 17, 2026
Reporting Period: Single event date (March 17, 2026)
Business Context: The filing serves as a Regulation FD disclosure to distribute a corporate slide presentation to the investment community. The presentation provides updates and summaries of the company's business.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. This document acts as a conduit for a slide presentation (Exhibit 99.1) rather than a financial statement itself.
Material Changes
No material financial changes or operational events are detailed within the text of this filing. The primary action is the release of a corporate presentation.
Guidance, Outlook, and Risks
- Management Commentary: The company distributes slide presentations at industry conferences to provide business updates.
- Legal Disclaimer: Information in Item 7.01 and Exhibit 99.1 is not deemed "filed" under Section 18 of the Exchange Act and is not subject to the liabilities of that section, nor is it incorporated by reference in other filings unless expressly stated.
- Guidance: Specific forward-looking guidance or outlook figures are not present in the filing text; they are contained within the attached Exhibit 99.1.
Investor Verification Checklist
- Review Exhibit 99.1 (Corporate slide presentation dated March 2026) for actual financial data, strategic updates, and guidance.
- Verify the trading status of Common Stock (Symbol: HBIO) on the NASDAQ Capital Market.
- Confirm that the presentation materials are not considered "filed" for liability purposes under Section 18 of the Exchange Act.